Literature DB >> 12723952

Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.

David C Labaree1, Jing-Xin Zhang, Heather A Harris, Craig O'Connor, Toni Y Reynolds, Richard B Hochberg.   

Abstract

We have synthesized derivatives of estradiol that are structurally modified to serve as "soft" estrogens and act within a geographically limited area of the body; estrogens without systemic action. We have previously shown with 16alpha-substituted analogues of estradiol that carboxylates proximal to the steroid ring neither bind to the estrogen receptor nor activate estrogen-responsive genes. However, when the carboxylic acid is masked as an ester, they bind to the receptor and stimulate estrogenic responses. Enzymatic hydrolysis through nonspecific esterases can inactivate these estrogens and thereby limit their area of action. Here, we describe our continued studies to design "soft" estrogens by synthesizing carboxylic acid esters of estradiol at the 7alpha-, 11beta-, and 15alpha-positions in the steroid nucleus at which bulky substituents are accommodated by the estrogen receptor. These compounds were tested for estrogen receptor binding (estrogen receptors alpha and beta), stimulation of an estrogen sensitive gene in Ishikawa cells in culture, and as substrates for enzymatic hydrolysis. Likely candidates were tested in in vivo assays for systemic and local estrogenic action. The biological studies showed that regardless of the point of attachment, all of the short-chain carboxylic acids, C-1 to C-3, were devoid of hormonal action, while many of the esters were estrogenic. The site on the steroid nucleus had great influence on hormonal activity and esterase hydrolysis. Formate esters at 7alpha and 15alpha were good estrogens, but lengthening the chain to acetate dramatically decreased hormonal activity. However, the 7alpha-formate esters were not enzymatically hydrolyzed. At 11beta, the acetate (methyl ester) was an effective estrogen, but increasing the chain length to propionate dramatically reduced hormonal activity. In general, the length of the alcohol from methyl to butyl had only a small effect on receptor binding, and as the size of the alcohol increased, so did esterase hydrolysis. One exception was the 11beta-acetate esters where increasing the alcohol moiety from methyl to ethyl eliminated estrogenic activity (Ishikawa cells) without affecting estrogen receptor binding. Several of the esters were tested in vivo, and two, the methyl and ethyl esters of estradiol-15alpha-formate, appeared to have the requisite properties (high local and low systemic activity) of superior "soft" estrogens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12723952     DOI: 10.1021/jm0204340

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Targeting the estrogen receptor with metal-carbonyl derivatives of estradiol.

Authors:  Robert N Hanson; Rein Kirss; Emmett McCaskill; Edward Hua; Pakamas Tongcharoensirikul; Sandra L Olmsted; David Labaree; Richard B Hochberg
Journal:  Bioorg Med Chem Lett       Date:  2012-01-08       Impact factor: 2.823

2.  Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy.

Authors:  Diana C Márquez-Garbán; Gang Deng; Begonya Comin-Anduix; Alejandro J Garcia; Yanpeng Xing; Hsiao-Wang Chen; Gardenia Cheung-Lau; Nalo Hamilton; Michael E Jung; Richard J Pietras
Journal:  J Steroid Biochem Mol Biol       Date:  2019-06-19       Impact factor: 4.292

3.  Synthesis and evaluation of 11β-(4-substituted phenyl) estradiol analogs: transition from estrogen receptor agonists to antagonists.

Authors:  Robert N Hanson; Edward Hua; J Adam Hendricks; David Labaree; Richard B Hochberg
Journal:  Bioorg Med Chem       Date:  2012-05-07       Impact factor: 3.641

4.  Synthesis and evaluation of 17α-E-20-(heteroaryl)norpregn-1,3,5(10),20 tetraene-3,17β-diols [17α-(heteroaryl)vinyl estradiols] as ligands for the estrogen receptor-α ligand binding domain (ERα-LBD).

Authors:  Sandra L Olmsted; Pakamas Tongcharoensirikul; Emmett McCaskill; Karla Gandiaga; David Labaree; Richard B Hochberg; Robert N Hanson
Journal:  Bioorg Med Chem Lett       Date:  2011-12-08       Impact factor: 2.823

5.  Fluorine-substituted cyclofenil derivatives as estrogen receptor ligands: synthesis and structure-affinity relationship study of potential positron emission tomography agents for imaging estrogen receptors in breast cancer.

Authors:  Jai Woong Seo; John S Comninos; Dae Yoon Chi; Dong Wook Kim; Kathryn E Carlson; John A Katzenellenbogen
Journal:  J Med Chem       Date:  2006-04-20       Impact factor: 7.446

6.  Synthesis and evaluation of 4-(substituted styryl/alkenyl)-3,5-bis(4-hydroxyphenyl)-isoxazoles as ligands for the estrogen receptor.

Authors:  Terra Haddad; Rachel Gershman; Robert Dilis; David Labaree; Richard B Hochberg; Robert N Hanson
Journal:  Bioorg Med Chem Lett       Date:  2012-07-15       Impact factor: 2.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.